Hosted on MSN

AstraZeneca’s Phase 1 Study on AZD9833: A New Hope for Advanced Breast Cancer

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% ...
Lupus Foundation of America

New Phase III study results support self-administered Saphnelo as an effective treatment option for systemic lupus erythematosus

It's more important than ever before for your elected officials to hear from you - don't miss your chance to turn Capitol ...
Fierce Pharma

AZ looks to grow reach in lupus with phase 3 win for self-administered Saphnelo

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...

AstraZeneca’s DAHLIA Lupus Study: Real‑World Data Could Strengthen Anifrolumab’s Long‑Term Investment Case

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

AstraZeneca: Oncology Dominance Justifies New All-Time Highs

The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...
Nasdaq

AstraZeneca Meets All Key Goals in Phase III Hypertension Study

AstraZeneca AZN reported positive top-line results from a late-stage study evaluating the safety, tolerability and efficacy of its investigational candidate, baxdrostat, in patients with uncontrolled ...